Addiction clinical trials at UCSF
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
In this study, the investigators are looking at how people make decisions about reward-related items, both monetary and food related after taking either the dopamine agonist bromocriptine or the COMT inhibitor tolcapone, in healthy control subjects. Subjects will fill self-report questionnaires and undergo an MRI scan.
San Francisco, California and other locations